J&J Sales in Q4 21 Miss Estimates, Upgrade Covid-19 Vaccine Sales to $3.5B in FY22
(Johnson&Johnson) Johnson&Johnson announced total sales of $24.80 billion in the fourth quarter of 2021, up 10.4% from the prior year but below estimates of $25.29 billion. In FY21, Johnson&Johnson posted…